| abstract |
The invention relates to solid state forms of N-((S)-2,3-Dihydroxy- propyl)-3-(2-fluoro-4-iodo-phenylamino)-isonicotinamide or its pharmaceutically acceptable salts, processes for their preparation, e.g. formula (I) and medical uses thereof. |